Nicole Chaves Petronzi
Senior Director, Global Regulatory Affairs Diagnostics Eli Lilly & Co.
Seminars
Wednesday 1st April 2026
From Regulation to Innovation: Lilly’s Strategic Evolution in the Wake of IVDR
2:00 pm
- The evolution of the Dx team in a pharma company
- How IVDR prompted deeper integration between Regulatory Affairs, Quality, Clinical, and Laboratory teams
- Which changes to the IVDR could streamline clinical trials in the EU
